The case highlights concerns regarding malpractice caps for PAs who have DSA agreements with physicians.
April 2022 FDA approvals include treatments for pediatric urinary tract infections, topical rosacea, vulvovaginal candidiasis, and various types of cancer.
A history of cancer more than 1 year before COVID-19 diagnosis not tied to increased mortality or hospitalization.
Reduced risk seen with earlier initiation of endoscopy, including lower risk for colorectal cancer diagnosed in women before 55 years of age.
In 2 minutes, the portable ATUSA system automatically scans the entire breast volume and provides 3D visualization of the breast tissue.
Barbara Goff, MD discusses ovarian cancer and how recognizing symptoms can lead to early detection and reduce misdiagnosis.
Sufficient circulating vitamin D concentration linked to lower risk for breast cancer in Hispanic/Latina women.
However, there were no statistically significant changes in rates by race.
However, higher risk seen for breakthrough infections and severe outcomes, especially for hematologic malignancies.
Clinicians should continue to counsel patients that false-positive results are an expected outcome of screening mammography. Age and breast density should be factored in when deciding the frequency of screening for average-risk women.
March 2022 FDA approvals include treatments for Alzheimer disease, endometrial carcinoma, metastatic melanoma, and a genetic seizure disorder.
Role of cumulative lifetime excess weight greater than role of excess BMI measured at a single time point.
COVID-19 research is expected to yield medical and scientific dividends for the treatment of influenza, cancer, cystic fibrosis, and other chronic diseases.
The phase 3 MAGNITUDE study assessed niraparib in combination with abiraterone acetate plus prednisone in patients with mCRPC with or without alterations in homologous recombination repair associated genes.
The case-based study aimed to analyze the prescribing behaviors of community oncologists treating patients with aRCC.
The real-world study compared the efficacy of neoadjuvant chemotherapy plus immunotherapy vs chemotherapy alone in patients with cT2-4bN0-3M0-1a pathological and imaging diagnosed MIBC.
Postdiagnosis intake of unprocessed red meat, processed meat not linked with recurrence or mortality risk in patients with stage III colon cancer.
Researchers used 2018 data from the National Health Interview Survey to investigate the association.
Investigators assessed the prevalence of and risk factors for colorectal neoplasia among patients aged 18 to 54 years.
Investigators assessed overall characteristics of postendoscopy upper gastrointestinal cancers and compared them with those of initially detected cancers.